Latest News
The famed short-seller bet against the AI cloud company six days before it reported. The quarter answered some of his concerns -- but left the biggest one standing.
Via The Motley Fool · August 12, 2026
Revenue fell 12% as project delays and production constraints weighed on results.
Via The Motley Fool · August 12, 2026
Revenue doubled year-over-year as scanner shipments accelerated.
Via The Motley Fool · August 12, 2026
STAAR Surgical (NASDAQ:STAA) reported second-quarter 2026 net sales of $93.5 million, up 111% from $44.3 million a year earlier, as growth in China, the Americas and parts of Europe contributed to what President and Chief Executive Officer Warren Foust called the company’s strongest first half of re
Via MarketBeat · August 12, 2026
Cogent Communications (NASDAQ:CCOI) Chief Executive Officer Dave Schaeffer said the company is positioned to benefit from growing artificial intelligence infrastructure demand through both higher internet traffic and increased demand for optical wavelength services, though he cautioned that deployme
Via MarketBeat · August 12, 2026
Sera Prognostics (NASDAQ:SERA) reported modest second-quarter revenue while outlining progress in payer engagement, Illinois Medicaid policy, clinical evidence and European regulatory preparations for its PreTRM Test-guided care platform.
Revenue for the quarter ended June 30 was $30,000, compared
Via MarketBeat · August 12, 2026
SKYX Platforms (NASDAQ:SKYX) reported record second-quarter revenue of $25.3 million, up 14% sequentially from $22.1 million in the first quarter and 10% from $23 million a year earlier. Management said the result marked its 10th consecutive quarter of year-over-year growth, despite continued declin
Via MarketBeat · August 12, 2026
Spero Therapeutics (NASDAQ:SPRO) used its second-quarter update to outline a strategic shift toward immune-mediated diseases, supported by the FDA approval of Utebzi and a new licensing agreement for SP001, an antibody candidate the company plans to develop initially for IgG4-related disease.
Presi
Via MarketBeat · August 12, 2026
RenovoRx (NASDAQ:RNXT) reported record second-quarter revenue as it expanded its commercial cancer-center network and advanced its clinical program for locally advanced pancreatic cancer.
For the quarter ended June 30, 2026, the company generated revenue of $909,000, up approximately 61% from $563,
Via MarketBeat · August 12, 2026
Red Robin Gourmet Burgers (NASDAQ:RRGB) reported second-quarter 2026 comparable sales growth and improved restaurant-level margins as the casual-dining chain continued to invest in value offerings, marketing and operational efficiency under its “First Choice” plan.
Chief Executive Officer Dave Pace
Via MarketBeat · August 12, 2026
comScore (NASDAQ:SCOR) reported second-quarter revenue declines and a sharp reduction in adjusted EBITDA as the media measurement company unveiled a restructuring plan aimed at lowering costs, simplifying operations and concentrating investment on selected growth opportunities.
Chief Executive Offi
Via MarketBeat · August 12, 2026
Perma-Fix Environmental Services (NASDAQ:PESI) reported second-quarter results that fell below management’s expectations, as delayed processing of Hanford-related waste pushed associated revenue into the second half of the year.
Revenue for the quarter was $12.9 million, down from $14.6 million a y
Via MarketBeat · August 12, 2026

3:34 PM – Selling all my PRI shares as we head into today’s close. After Monday’s break below the 10 DMA, the stock has continued to exhibit bearish techni
Via Talk Markets · August 12, 2026
無論你是電子煙新手還是老手,選擇適合自己的產品都需要一定的知識儲備。逐雲者提供了從入門級到進階級的完整產品線,涵蓋SP2S、RELX、LANA、MEHA等多個知名品牌。基礎維護的正確方式定期清潔能顯著改善電子煙的使用體驗。建議每週用酒精棉籤輕輕擦拭主機接口處,清除積累的灰塵和殘留物。選擇逐雲者來探索更多品牌和
Via Talk Markets · August 12, 2026
This Canadian dividend stock pays investors every month and yields close to 11%. Here's what's behind the payout and the risk.
Via The Motley Fool · August 12, 2026
Revenue surged 82% year-over-year as hospital adoption doubled to 20 sites.
Via The Motley Fool · August 12, 2026
China’s science surge is reshaping global drug development as Washington moves to counter Beijing’s growing influence in medicine.
Via Benzinga · August 12, 2026
The market can see the demand just fine. The discount is about what delivering it will cost.
Via The Motley Fool · August 12, 2026
Gold offers lower costs and stability, while mining equities deliver higher returns with greater volatility. Which suits your portfolio?
Via The Motley Fool · August 12, 2026
Let’s assess Enbridge and Suncor Energy to determine a better buy for income-seeking investors.
Via The Motley Fool · August 12, 2026
Michael Burry said the market's unusually long stretch without a broad selloff is a warning sign of a reversal.
Via Benzinga · August 12, 2026
CEO Tabar discusses $28.8M revenue growth and major GPU deployment agreements.
Via The Motley Fool · August 12, 2026
Demand for artificial intelligence computing capacity is rising exponentially, according to CEO Arkady Volozh.
Via The Motley Fool · August 12, 2026
Trump faces a lawsuit challenging Truth API’s paid early access to his market-moving Truth Social posts, citing First Amendment concerns.
Via Benzinga · August 12, 2026
Canada’s AI boom may be less about flashy startups and more about the unglamorous companies helping businesses adopt AI safely.
Via The Motley Fool · August 12, 2026